Francois Nader is President & Director at NPS PHARMACEUTICALS INC (NPSP). They have made 4 open-market trades across 3 companies since 2010, most recently 2026-04-30.
CIK 0001365343
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $661K since 2011, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TALS | BUY | 2022-07-19 | 2022-09-13 | $3.61 | $500K | -35.0% | -35.8% | -64.7% |
| MRNA | SELL | 2022-05-10 | 2022-05-12 | $136.10 | $870K | -0.2% | -11.5% | +31.7% |
| NPSP | SELL · 10b5-1 | 2013-09-26 | 2013-09-30 | $32.93 | $6.4M | N/A | N/A | N/A |
| NPSP | SELL · 10b5-1 | 2013-04-08 | 2013-04-10 | $11.32 | $5.1M | N/A | N/A | N/A |
| NPSP | BUY | 2011-11-09 | 2011-11-10 | $5.36 | $161K | N/A | N/A | N/A |
| NPSP | SELL | 2010-02-03 | 2010-04-02 | $3.37 | $65K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.